Evidence map›Paper›PMID 25867831›Full record

ArticleMolecules (Basel, Switzerland)2015

Recycling antibiotics into GUMBOS: a new combination strategy to combat multi-drug-resistant bacteria.

Marsha R Cole, Jeffery A Hobden, Isiah M Warner

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Fluoroquinolone-Based Organic Salts (GUMBOS) with Antibacterial Potential.International journal of molecular sciences · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Recycling Old Antibiotics with Ionic Liquids.Antibiotics (Basel, Switzerland) · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Marsha R ColeCommodity Utilization, Southern Regional Research Center, Agricultural Research Services, United States Department of Agriculture, New Orleans, LA 70124, USA. marsha.cole@ars.usda.gov.
Jeffery A HobdenDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Medical Center, New Orleans, LA 70112, USA. jhobde@lsuhsc.edu.
Isiah M WarnerDepartment of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA. iwarner@lsu.edu.
Louisiana State University · USSouthern Regional Research Center · US

Funding

Enhanced Protein Separations Using Molecular MicellesR01GM079670 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI WARNER, ISIAH M · 2007 to 2009
$779k
NIGMS NIH HHS R01 GM079670NIGMS NIH HHS R01 GM79670
6 · The paper itself

Abstract

The emergence of multi-drug-resistant bacteria, coupled with the lack of new antibiotics in development, is fast evolving into a global crisis. New strategies utilizing existing antibacterial agents are urgently needed. We propose one such strategy in which four outmoded β-lactam antibiotics (ampicillin, carbenicillin, cephalothin and oxacillin) and a well-known antiseptic (chlorhexidine di-acetate) were fashioned into a group of uniform materials based on organic salts (GUMBOS) as an alternative to conventional combination drug dosing strategies. The antibacterial activity of precursor ions (e.g., chlorhexidine diacetate and β-lactam antibiotics), GUMBOS and their unreacted mixtures were studied with 25 clinical isolates with varying antibiotic resistance using a micro-broth dilution method. Acute cytotoxicity and therapeutic indices were determined using fibroblasts, endothelial and cervical cell lines. Intestinal permeability was predicted using a parallel artificial membrane permeability assay. GUMBOS formed from ineffective β-lactam antibiotics and cytotoxic chlorhexidine diacetate exhibited unique pharmacological properties and profound antibacterial activity at lower concentrations than the unreacted mixture of precursor ions at equivalent stoichiometry. Reduced cytotoxicity to invasive cell types commonly found in superficial and chronic wounds was also observed using GUMBOS. GUMBOS show promise as an alternative combination drug strategy for treating wound infections caused by drug-resistant bacteria.

Indexed as

Drug Resistance, BacterialDrug Resistance, MultipleAnimalsAnti-Bacterial AgentsBacteriabeta-LactamsCell LineChlorhexidineDrug SynergismDrug Therapy, CombinationHumansInhibitory Concentration 50Intestinal AbsorptionMiceMicrobial Sensitivity TestsPermeabilityAnti-Bacterial Agentsbeta-LactamsChlorhexidineSalts

Identifiers

PMID25867831
PMCPMC6272440
OpenAlexW2080763657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.